Alternatives to Ambrx

Clinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.

A global oncology company developing and commercializing innovative cancer treatments.

Global biopharmaceutical company focused on oncology and neuroscience treatments.

Genomics and AI-driven health intelligence company focused on extending healthy human life.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Developing a new histotripsy therapeutic platform for cancer treatment.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

Engineering scalable gene therapies for broader patient populations.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

An end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials, focusing on lung and heart disease.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Immunotherapy company targeting oncology and autoimmune diseases.

A biotechnology company focused on oncology drug discovery.

Clinical-stage immunotherapy company developing novel treatments for cancer.

Scalable, one-time curative in-vivo gene editing therapies.

South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.

Platform designed to cut cell and gene therapy production costs.

Advancing targeted alpha therapies.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Biopharmaceutical company developing T-cell therapies for solid tumor cancers.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

AI drug discovery startup that learns directly from patient biology to identify and design novel medicines, focusing on oncology and fibrosis.

Pioneering next-generation bispecific ADCs for cancer treatment.

Developing an automated platform for liquid biopsy sample preparation.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Global supplier of life science research tools, including antibodies, reagents, and assays.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

A vertically-integrated procurement platform for the life sciences industry.

A global leader in clinical pharmacology and bioanalytical sciences.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Developing novel immunotherapies and diagnostics for cancer.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A biotechnology company developing genetic therapies for rare disorders.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

Developing gene editing therapies to lower cholesterol.